Galectin Therapeutics
GALT
GALT
84 hedge funds and large institutions have $21M invested in Galectin Therapeutics in 2025 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 24 increasing their positions, 20 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
84
Holders Change
-8
Holders Change %
-8.7%
% of All Funds
1.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
24
Reduced
20
Closed
21
Calls
$355K
Puts
$1.05M
Net Calls
-$691K
Net Calls Change
+$1.12M
Top Buyers
| 1 |
Jane Street
New York
|
+$1.58M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$384K |
| 3 |
LPL Financial
San Diego,
California
|
+$366K |
| 4 |
Millennium Management
New York
|
+$305K |
| 5 |
VCM
Vivaldi Capital Management
Chicago,
Illinois
|
+$246K |
Top Sellers
| 1 |
BlackRock
New York
|
-$1.1M |
| 2 |
GWM
Geneos Wealth Management
Englewood,
Colorado
|
-$902K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$394K |
| 4 |
YIH
Y-Intercept (HK)
Hong Kong
|
-$287K |
| 5 |
AWS
Atria Wealth Solutions
New York
|
-$227K |
